Mylan has plans to produce a generic asthma inhaler


Mylan is looking for approval from the FDA to begin producing a generic version of Advair, which is set to lose its patent protections later on this year. Advair is an asthma inhaler, and currently one of the country’s best selling drugs. However, analysts are weary of how much Mylan can raise prices in the current political climate.

Read the source article at Pharmacy Choice

About the Author

Related Posts

Leave a Reply